FI940469A0 - Kinolinderivat som immunostimulanter - Google Patents

Kinolinderivat som immunostimulanter

Info

Publication number
FI940469A0
FI940469A0 FI940469A FI940469A FI940469A0 FI 940469 A0 FI940469 A0 FI 940469A0 FI 940469 A FI940469 A FI 940469A FI 940469 A FI940469 A FI 940469A FI 940469 A0 FI940469 A0 FI 940469A0
Authority
FI
Finland
Prior art keywords
immunostimulants
quinoline derivatives
quinoline
derivatives
Prior art date
Application number
FI940469A
Other languages
English (en)
Finnish (fi)
Other versions
FI940469A (sv
Inventor
Mikel P Moyer
James W Mcfarland
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI940469A0 publication Critical patent/FI940469A0/sv
Publication of FI940469A publication Critical patent/FI940469A/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • C07D215/44Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI940469A 1991-08-02 1994-02-01 Kinolinderivat som immunostimulanter FI940469A (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74082591A 1991-08-02 1991-08-02
PCT/US1992/005435 WO1993003030A1 (en) 1991-08-02 1992-07-01 Quinoline derivatives as immunostimulants

Publications (2)

Publication Number Publication Date
FI940469A0 true FI940469A0 (sv) 1994-02-01
FI940469A FI940469A (sv) 1994-02-01

Family

ID=24978239

Family Applications (1)

Application Number Title Priority Date Filing Date
FI940469A FI940469A (sv) 1991-08-02 1994-02-01 Kinolinderivat som immunostimulanter

Country Status (8)

Country Link
US (1) US5506235A (sv)
EP (1) EP0597003A1 (sv)
JP (1) JPH06504294A (sv)
CA (1) CA2114727C (sv)
FI (1) FI940469A (sv)
IE (1) IE922485A1 (sv)
PT (1) PT100751A (sv)
WO (1) WO1993003030A1 (sv)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9510757D0 (en) * 1994-09-19 1995-07-19 Wellcome Found Therapeuticaly active compounds
DK0885198T3 (da) 1996-03-05 2002-03-25 Astrazeneca Ab 4-Anilinoquinazolinderivater
ATE300521T1 (de) * 1996-09-25 2005-08-15 Astrazeneca Ab Chinolin-derivate die den effekt von wachstumsfaktoren wie vegf vezögern
US5919776A (en) * 1996-12-20 1999-07-06 Merck & Co., Inc. Substituted aminoquinolines as modulators of chemokine receptor activity
GB9910579D0 (en) 1999-05-08 1999-07-07 Zeneca Ltd Chemical compounds
GB9910580D0 (en) 1999-05-08 1999-07-07 Zeneca Ltd Chemical compounds
IL151626A0 (en) 2000-04-07 2003-04-10 Astrazeneca Ab Quinazoline compounds
AU2001295791A1 (en) 2000-11-02 2002-05-15 Astrazeneca Ab 4-substituted quinolines as antitumor agents
AU2002210714A1 (en) 2000-11-02 2002-06-11 Astrazeneca Ab Substituted quinolines as antitumor agents
SE0004056D0 (sv) * 2000-11-06 2000-11-06 Astrazeneca Ab N-type calcium channel antagonists for the treatment of pain
GB0215823D0 (en) 2002-07-09 2002-08-14 Astrazeneca Ab Quinazoline derivatives
GB0225579D0 (en) 2002-11-02 2002-12-11 Astrazeneca Ab Chemical compounds
GEP20084572B (en) 2003-12-23 2008-12-25 Pfizer Novel quinoline derivatives
DE102004063223A1 (de) * 2004-12-22 2006-07-13 Schering Ag Chinolinderivat, dessen Verwendung, Herstellung und dieses enthaltendes Arzneimittel
WO2006066955A1 (de) * 2004-12-22 2006-06-29 Bayer Schering Pharma Aktiengesellschaft Chinolinderivat, dessen verwendung, herstellung und dieses enthalten­des arzneimittel
DE102006029445A1 (de) 2006-06-21 2007-12-27 Bayer Schering Pharma Ag Neue 3-Cyano-chinoline als Kinase-Inhibitoren
DE102006029446A1 (de) * 2006-06-21 2007-12-27 Bayer Schering Pharma Ag Neue 3-substituierte-Chinoline als Kinase-Inhibitoren
DE102007024470A1 (de) 2007-05-24 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Neue Sulfoximin-substituierte Chinolin- bzw. Chinazolinderivate als Kinase-Inhibitoren
EP2072502A1 (de) 2007-12-20 2009-06-24 Bayer Schering Pharma Aktiengesellschaft Sulfoximid-substituierte Chinolin- und Chinazolinderivate als Kinase-Inhibitoren
WO2011054433A1 (en) 2009-11-07 2011-05-12 Merck Patent Gmbh Heteroarylaminoquinolines as tgf-beta receptor kinase inhibitors
BR112015022417A2 (pt) 2013-03-14 2017-07-18 Convergene Llc métodos e composições para inibição de proteínas contendo bromodomínio
EP4050005A1 (en) * 2015-11-25 2022-08-31 Convergene Llc Bicyclic bet bromodomain inhibitors and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB980394A (en) * 1962-09-12 1965-01-13 Allen & Hanburys Ltd Quinaldinium derivatives
FR5389M (sv) * 1966-02-04 1967-09-18
FR2047882A1 (en) * 1969-06-20 1971-03-19 Roussel Uclaf Analgesic antiinflammatory 4-(2-alkoxy - phenylamino-quinolines and intermediates
US3919238A (en) * 1973-06-06 1975-11-11 Morton Norwich Products Inc 9-(Substituted amino)imidazo(4,5-f) quinolines
US3859291A (en) * 1973-10-01 1975-01-07 Morton Norwich Products Inc 9-(p-anisidino)-7-methyl-(1h)-pyrazolo(3,4-f)quinoline
GB1496371A (en) * 1975-08-18 1977-12-30 Serdex 4-amino-quinoline derivatives process for their preparation and therapeutic applications thereof
EP0187705A3 (en) * 1985-01-08 1988-05-11 Norwich Eaton Pharmaceuticals, Inc. Imidazo(4,5-f)quinolines useful as immunomodulating agents
US4716168A (en) * 1985-01-08 1987-12-29 Norwich Eaton Pharmaceuticals, Inc. Imidazo(4,5-f)quinolines useful as immunomodulating agents
IL89029A (en) * 1988-01-29 1993-01-31 Lilly Co Eli Fungicidal quinoline and cinnoline derivatives, compositions containing them, and fungicidal methods of using them

Also Published As

Publication number Publication date
IE922485A1 (en) 1993-02-10
CA2114727C (en) 1996-12-10
US5506235A (en) 1996-04-09
PT100751A (pt) 1993-09-30
JPH06504294A (ja) 1994-05-19
EP0597003A1 (en) 1994-05-18
FI940469A (sv) 1994-02-01
CA2114727A1 (en) 1993-02-18
WO1993003030A1 (en) 1993-02-18

Similar Documents

Publication Publication Date Title
FI940469A (sv) Kinolinderivat som immunostimulanter
DK0516349T3 (da) 2-hydroxy-2-phenylethylamin-derivater som beta-3-adrenoceptoragonister
NO953406D0 (no) Pyrrolo-pyridinderivater
MX9201823A (es) Derivados de quinolina.
FI933167A0 (fi) N-alkylkinuklidiniumsalter som substans-p antagonister
DE69208877D1 (de) Chinuclidinderivate
NO922182L (no) Krystallinske oksatiolan-derivater
DK0533268T3 (da) Benzanilidderivater som 5HT-1D antagonister
FI921182A (fi) Velangummi som snabbt hydratiseras
DK0606248T3 (da) Heteroarylaminer som hidtil ukendte acetylcholinesteraseinhibitorer
FI933505A (fi) Foerfarande foer framstaellning av etenpolymerer med en reducerad halt avkomponenter som kan extraheras med hexan
FI934568A0 (fi) Hydrofobisitet som aostadkommits med metalljonaktivering
NO960371D0 (no) Piperazinderivater som ter
DE69132519D1 (de) Quinolin-Derivate
FI922973A (fi) Tokoferolblandning foer anvaendning som antioxidant foer krusmyntolja i tuggummi
DK0531548T3 (da) Carbostyril-forbindelser som anti-thrombotiske midler
FI925763A0 (fi) Fungicida 2-imidazolin-5-on- och 2-imidazolin-5-tionderivat
FI925284A (fi) Inkapslade partiklar anvaendbara som kontrastmedel i kompositioner och metoder, som anvaends vid ultraljud- och roentgenavbildning
NO930520D0 (no) Bifenyl-substituerte kinolinderivater
NO920420L (no) 3-quinuklidin-derivater
NO920220L (no) Sulfonamid-derivater
FI925469A (fi) Tiazolylsubstituerade kinolylymetoxifenylaettiksyraderivat
FI923555A (fi) Foerfarande foer framstaellning av mattor som bestaor av minst tvao med varandra bundna skikt
FI921666A (fi) Indolin- och dihydrokinolinfoereningar som oeppnare av kaliumkanal
FI930342A0 (fi) Pentapeptider som reglerar immun- och nervsystem

Legal Events

Date Code Title Description
FD Application lapsed